[Clinico-immunologic aspects of patients with chronic obstructive bronchitis. Immunomodulating therapy].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001991:Bronchitis / Q000188:drug therapy / Q000276:immunology*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007665:Ketotifen / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use*; D008875:Middle Aged; D013450:Sulfones / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D014498:Uracil / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D013450:Sulfones; D007978:Levamisole; C023367:diucifon; D014498:Uracil; D007665:Ketotifen
Kliniko-immunologicheskaia kharakteristika bol'nykh khronicheskim obstruktivnym bronkhitom. Immunomoduliruiushchaia terapiia.